iCliniq Logo
HomeHealth articlesCardiologypulmonary embolism

Pulmonary Embolism and Infarction: Symptoms, Diagnosis, and Treatment.

Verified data
0

4 min read

Share

Outline

Pulmonary infarction (PI) is caused by blockage of distal pulmonary arteries resulting in tissue death. The primary etiology of PI is pulmonary embolism.

Medically reviewed byDr. Muhammad Zohaib Siddiq

Published At September 7, 2023
Reviewed AtApril 8, 2024

Introduction:

Pulmonary infarction results from the obstruction of distal pulmonary arteries leading to ischemia (insufficient blood supply to lungs), hemorrhage (bleeding from a damaged blood vessel), and eventually ending up in necrosis (death) of lung parenchyma. Pulmonary infarction is caused by various reasons, but one of the main causes of pulmonary infarction is pulmonary embolism.

What Is Pulmonary Embolism?

Pulmonary embolism is the obstruction or blockage of the pulmonary artery caused by a blood clot (thrombus). This blood clot is either formed in the pulmonary blood vessel or is carried in the bloodstream, which is formed somewhere else in the body (embolus). The significant symptom of pulmonary embolism is shortness of breath. Pulmonary arteries are blood vessels that transport blood from the heart to the lungs, and in the lungs, the exchange of gasses takes place, and the blood returns its oxygen to the heart. From the heart, the blood containing oxygen is pumped to different parts of the body, thus providing oxygen to all the tissues in the body.

When this pulmonary artery is blocked or obstructed because of a blood clot (thrombus) or embolus, tissues will not receive sufficient amounts of oxygen. A large embolus can cause so much blockage that the heart is unable to pump enough blood through pulmonary arteries, and this leads to a decrease in blood pressure. Also, big-sized embolisms can cause obstruction of the blood flow to the lungs leading to the death of lung tissues, and this condition is called pulmonary infarction. Pulmonary infarction is a fatal condition, but it can be reversed.

Usually, the body splits up the smaller clots quickly when compared to larger ones so that the damage can be minimal. Large clots take too much time to disintegrate, and this leads to the scar forming on the blood vessel leading to increased blood pressure in the blood vessels of the lungs. This condition is known as pulmonary hypertension, and this causes permanent damage to the lungs.

What Are The Risk Factors Of Pulmonary Infarction?

Anything which increases the chance of getting a disease is known as a risk factor. The presence of a risk factor indicates that the person is more susceptible to the disease. The risk factors of pulmonary infarction include:

  • Smoking: This is considered a major risk factor for not only pulmonary infarction but also pulmonary embolism.

  • Age and Height: The population who are young (below 40 years), increased height are more likely to develop pulmonary infarction.

  • Sickle Cell Disease: Patients with sickle cell hemoglobin (HBS) are likely to develop vascular infarction due to the blockage. The sickle-shaped cells adhere directly to the pulmonary artery, leading to pulmonary blockage and infarction.

  • Prolonged Hospitalization: People who are bedridden for longer periods are more likely to develop embolus, thus leading to the formation of pulmonary infarction.

  • Leg Surgeries: People who have undergone hip and knee joint replacements are at risk of developing embolism. This is mainly due to immobilization after surgery. Hence patients are advised to go back to their routine daily work as soon as possible after surgery.

How To Diagnose Pulmonary Infarction?

The diagnosis of pulmonary infarction is mainly done by imaging tests and correlating them with the clinical signs and symptoms.

  1. Computed Tomography (CT): This is the most commonly used diagnostic tool to determine pulmonary infarction. Computed tomography associated with an infarction looks like a feeding vessel appearance of a lung nodule along with the blood vessel. It is also called a vessel sign, and it appears in a semicircular shape with central translucency.

  2. X-rays: X-rays of the chest region are the primary diagnostic tool to give the first indication of infarction. The findings in the X-ray appear as follows:

  • Hampton's Hump: A dome-shaped opacification in the lung commonly caused due to pulmonary embolism and lung infarction

  • Westermark's Sign: The chest X-ray shows diffused translucency due to decreased blood flow to the lungs. The foremost cause of insufficient blood flow is pulmonary embolism.

  • Fleischner Sign: It is mostly seen in the central pulmonary artery that is blocked due to embolism.

How To Treat Pulmonary Infarction and Embolism?

Pulmonary infarction leads to respiratory failure and hemodynamic collapse (fluctuating and abnormal blood pressure). These two are life-threatening situations that need to be addressed immediately. If not treated in time, patients suffer from shock and cardiorespiratory arrest (improper heart and lung function), which are permanent and can lead to death. In order to prevent these fatal situations, patients should be placed on:

  • Supportive Care Management: Relieving the symptoms and maintaining blood oxygen levels is the primary focus of supportive care. Oxygen support, administering analgesics (for pain relieving), and maintaining adequate blood pressure is done at this stage. In case of respiratory failure, a patient is placed on a mechanical ventilator to enhance oxygen supply to the tissues.

  • Anticoagulation Therapy: Anticoagulants (blood thinners) are injected intravenously so that they can act quickly by dissolving the clot. Warfarin, Heparin, and Apixaban are the choice of anticoagulants.

How To Prevent Pulmonary Infarction Caused By Pulmonary Embolism?

Due to the hazards caused by pulmonary embolism and its limited treatment options, doctors suggest preventing blood clot formation in the veins of people who are at risk of developing embolism. People are advised to have good physical activity every day and walk around as much as possible. People traveling are suggested to walk for a few minutes every two hours during their journey. Along with this, the patient's health condition should also be checked thoroughly.

Anticoagulants As Preventive Measure:

People who are at risk of developing embolus are advised to have anticoagulants as a part of a preventive regimen. Among the anticoagulants, Heparin is the most commonly prescribed drug. Heparin can be administered in two forms, namely:

  • Conventional Heparin.

  • Low molecular weight Heparin.

Heparin is mostly suggested in patients who have undergone leg surgeries. It is injected beneath the skin every 6 to 12 hours or until the patient gets up and starts walking. People who are suffering from cardiac diseases, obesity, immobility, and prolonged hospitalization are advised with minor doses of Heparin. The advantage of low doses of Heparin is that it does not cause any bleeding disorders; instead, it causes the oozing of blood from small wounds.

Conclusion:

Pulmonary embolism is the primary cause of pulmonary infarction. Through investigation, procedures should be carried out as pulmonary infarction could mimic those of lung nodules. Patients are educated regarding the stoppage of smoking, as tobacco is considered the major risk factor. Since pulmonary infarction is a fatal condition, maintenance of adequate blood flow to the tissues, followed by anticoagulation therapy, is recommended. A multidisciplinary approach involves surgeons, cardiologists, hematologists, and internal medicine specialists working as a team to treat pulmonary infarction.

Listen to related tracks in our music library

Frequently Asked Questions

The term "pulmonary embolism" describes the occlusion of the pulmonary arteries by blood clots, which usually begin in the legs or pelvis. Conversely, pulmonary infarction happens when restricted blood flow causes tissue damage and lung cell death, leading to localized tissue death. Pulmonary infarction is the result of a severe or untreated pulmonary embolism.

Several risk factors are involved in the pulmonary embolism development process. A history of deep vein thrombosis, surgery, extended periods of immobility, certain medical disorders, including cancer, and hereditary factors that impact blood clotting are among them. The use of estrogen-containing drugs, such as hormonal contraceptives or hormone replacement treatment, obesity, smoking, and smoking are additional risk factors.

Anticoagulant drugs are commonly used to treat pulmonary embolisms to stop the formation of new clots while allowing the body time to dissolve already-formed clots. Thrombolytic treatment can sometimes be used to dissolve huge clots quickly. In addition, certain individuals may benefit from procedures like surgically removing the clot or implanting a filter in the inferior vena cava.

A pulmonary embolism may pose a serious threat to life. It can cause fatal consequences and other severe side effects, such as respiratory failure, if it is not treated quickly and efficiently. The prognosis for patients with pulmonary embolism is greatly improved by prompt diagnosis and proper medical care.

With the right care, most patients recover fully from pulmonary embolisms, but others may have persistent symptoms, including exhaustion, difficulty breathing, or intolerance to physical exertion. Long-term consequences, such as recurring blood clotting problems or chronic pulmonary hypertension, may occur in certain circumstances and require continuing medical care.

Indeed, the risk of pulmonary embolism can rise during pregnancy. This increased risk is exacerbated by changes in blood clotting factors, hormone levels during pregnancy, and reduced mobility. Furthermore, an increased risk of developing pulmonary embolism is associated with certain pregnancy problems, such as preeclampsia or cesarean birth.

People may modify their lifestyles to lower their risk of pulmonary embolism by engaging in regular physical exercise, avoiding extended periods of immobility, and adopting healthy behaviors such as avoiding smoking and drinking enough water. Seeking advice from a healthcare provider is essential for those with certain risk factors, such as a family history of clotting problems or blood clots, to develop personalized preventative measures.

Travel, particularly extended periods of immobility, such as long flights or vehicle journeys, can increase the risk of pulmonary embolism. Long periods spent sitting still can cause blood to pool in the legs, which raises the possibility that blood clots will develop and proceed to the lungs. This threat can be decreased by traveling with adequate hydration and taking regular walking stops.

Although no known natural treatments specifically prevent pulmonary embolism, leading a healthy lifestyle can help maintain cardiovascular overall health and may reduce the risk. Engaging in consistent physical activity, maintaining proper hydration, and avoiding extended periods of immobility are general behaviors that may lower the risk of blood clots and pulmonary embolism.

Recurrence of pulmonary embolism is possible, particularly in those with persistent risk factors or a history of blood coagulation abnormalities. To lower the chance of recurrence, those who have had a pulmonary embolism must carefully collaborate with medical specialists to identify and treat underlying risk factors and follow any recommended preventative measures.

Anticoagulant drugs are the primary and most successful treatment for pulmonary embolism; in certain situations, thrombolytic therapy or surgery may also be necessary. Although lifestyle modifications and complementary therapies may improve general health, they are not recognized as substitute treatments for pulmonary embolism. They should not be replaced with measures that doctors recommend.

Although pulmonary embolism can happen at any time after surgery, the first few weeks after the procedure usually carry the highest risk. Many surgical-related variables cause this increased risk, blood clotting factor changes and immobility during recovery. During this postoperative phase, healthcare providers must regularly monitor patients to identify and rapidly handle any possible complications.

Pulmonary embolism may have a genetic propensity. It may result from blood clots, which can be more likely to form due to certain hereditary variables that influence blood coagulation. People who have a family history of clotting issues must be aware of this risk and seek advice from medical specialists on the best preventive measures.

Source Article IclonSourcesSource Article Arrow

Tags:

pulmonary embolism

Ask your health query to a doctor online

Cardiology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.